Stem Cell Therapy for Sports Injuries: What Weekend Warriors Need to Know

A 36-month clinical trial showed zero adverse events and 57% pain reduction when stem cells were injected into torn rotator cuffs. Here’s what weekend warriors and recreational athletes need to know about MSC therapy for sports injuries.

Lire la suite...

Intravenous UC-MSCs for Ischemic Stroke: What the MERIT Phase 1 Trial Tells Us

The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.

Lire la suite...

MSC Therapy for Graft-versus-Host Disease: What 15 RCTs and a Biomarker-Guided Trial Tell Us

A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.

Lire la suite...

The Ethics of Stem Cell Research: Clearing Up the Most Common Misconceptions

Few areas of biomedical research have generated as much ethical debate as stem cell science. From heated political controversies over embryonic stem cell research to public confusion about what stem cells actually are, the field has been surrounded by misconceptions, misinformation, and genuine ethical complexity. For patients considering stem cell...

Lire la suite...
Top